Checkpoint Kinase 1 Promotes the Development of Pulmonary Arterial Hypertension.
作者信息
Satoh Kimio, Kikuchi Nobuhiro, Kurosawa Ryo, Shimokawa Hiroaki
机构信息
From the Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
出版信息
Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1504-1506. doi: 10.1161/ATVBAHA.119.312969. Epub 2019 Jul 24.
PMID:31339778
Abstract
摘要
相似文献
1
Checkpoint Kinase 1 Promotes the Development of Pulmonary Arterial Hypertension.关卡激酶1促进肺动脉高压的发展。
Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1504-1506. doi: 10.1161/ATVBAHA.119.312969. Epub 2019 Jul 24.
2
Transthoracic Pulmonary Artery Denervation.经胸肺动脉去神经支配术
Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):979-981. doi: 10.1161/ATVBAHA.119.312591.
3
Still puzzling about a clear definition of pulmonary arterial hypertension in newborns.仍在为新生儿肺动脉高压的明确定义而困惑。
Eur Respir J. 2019 Mar 28;53(3). doi: 10.1183/13993003.00005-2019. Print 2019 Mar.
4
Response: Still puzzling about a clear definition of pulmonary arterial hypertension in newborns.回应：仍在困惑如何清晰界定新生儿肺动脉高压。
Eur Respir J. 2019 Mar 28;53(3). doi: 10.1183/13993003.00135-2019. Print 2019 Mar.
5
PDA with Eisenmenger Syndrome Masquerading as Idiopathic Pulmonary Hypertension.伪装成特发性肺动脉高压的动脉导管未闭合并艾森曼格综合征
J Assoc Physicians India. 2020 Jan;68(1):53.
6
The Pathobiology of Pulmonary Arterial Hypertension.肺动脉高压的病理生理学。
Cardiol Clin. 2022 Feb;40(1):1-12. doi: 10.1016/j.ccl.2021.08.001.
7
[Efficacy of emergent systemic-pulmonary arterial anastomosis (Potts shunt) in a child with severe idiopathic pulmonary hypertension].[急诊体肺动脉吻合术（Potts分流术）治疗儿童重度特发性肺动脉高压的疗效]
Zhonghua Xin Xue Guan Bing Za Zhi. 2021 Jun 24;49(6):621-623. doi: 10.3760/cma.j.cn112148-20200803-00612.
8
Commentary: Will the reversed Potts shunt replace lung transplantation for children with end-stage pulmonary arterial hypertension?述评：反向Potts分流术会取代终末期肺动脉高压患儿的肺移植吗？
J Thorac Cardiovasc Surg. 2021 Mar;161(3):1150-1151. doi: 10.1016/j.jtcvs.2020.11.024. Epub 2020 Nov 19.
9
Multilevel omics: A next step on the way to understanding pulmonary arterial hypertension?多组学：通往理解肺动脉高压之路的下一步？
Thorax. 2019 Apr;74(4):317-318. doi: 10.1136/thoraxjnl-2018-212840. Epub 2019 Jan 24.
10
Real-World Data for Pulmonary Arterial Hypertension.肺动脉高压的真实世界数据。
Chest. 2019 Apr;155(4):653-654. doi: 10.1016/j.chest.2019.01.031.
引用本文的文献
1
DNA damage response signaling: A common link between cancer and cardiovascular diseases.DNA 损伤反应信号转导：癌症与心血管疾病的共同联系。
Cancer Med. 2023 Feb;12(4):4380-4404. doi: 10.1002/cam4.5274. Epub 2022 Sep 26.
2
Therapeutic Potential of Regorafenib-A Multikinase Inhibitor in Pulmonary Hypertension.雷戈拉非尼在肺动脉高压中的治疗潜力：一种多激酶抑制剂。
Int J Mol Sci. 2021 Feb 2;22(3):1502. doi: 10.3390/ijms22031502.
Zotero 插件